Arlene Reisman
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Molecular Biology top 10%
- Cancer Research top 5%
- Infectious Diseases top 5%
- Co-authors
- Shrividya IyerKeith D. WilnerBenjamin SolomonFiona BlackhallTony MokEnriqueta FelipDong‐Wan KimJolanda Paolini
- Topics
- Lung Cancer Treatments and Mutations (18 papers)Lung Cancer Diagnosis and Treatment (13 papers)Chronic Lymphocytic Leukemia Research (10 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Arlene Reisman
51 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Pulmonary and Respiratory Medicine 2.3k
- Oncology 1.9k
- Molecular Biology 755
- Cancer Research 631
- Infectious Diseases 544
Countries citing papers authored by Arlene Reisman
This map shows the geographic impact of Arlene Reisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene Reisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene Reisman more than expected).
Fields of papers citing papers by Arlene Reisman
This network shows the impact of papers produced by Arlene Reisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene Reisman. The network helps show where Arlene Reisman may publish in the future.
Co-authorship network of co-authors of Arlene Reisman
This figure shows the co-authorship network connecting the top 25 collaborators of Arlene Reisman. A scholar is included among the top collaborators of Arlene Reisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene Reisman. Arlene Reisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 23 | |
| 4 | 9 | |
| 5 | 15 | |
| 6 | 1 | |
| 7 | 82 | |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 58 | |
| 11 | First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancerbreakdown → | 2327 |
| 12 | 1 | |
| 13 | 25 | |
| 14 | Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Studybreakdown → | 402 |
| 15 | 25 | |
| 16 | 78 | |
| 17 | 72 | |
| 18 | 30 | |
| 19 | 10 | |
| 20 | 11 |
About Arlene Reisman
Arlene Reisman is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Oncology (1.9k citations) and Cancer Research (631 citations). Arlene Reisman has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Shrividya Iyer, Keith D. Wilner, Benjamin Solomon, Fiona Blackhall, Tony Mok, Enriqueta Felip, Dong‐Wan Kim, Jolanda Paolini, Yi‐Long Wu and Tarek Mekhail. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.